Segalés Joaquim, Sibila Marina
Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, 08193 Barcelona, Catalonia, Spain.
Departament de Sanitat i Anatomia Animals, Facultat de Veterinària, Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, 08193 Barcelona, Catalonia, Spain.
Vet Sci. 2022 Mar 2;9(3):110. doi: 10.3390/vetsci9030110.
Current knowledge on porcine circovirus diseases (PCVD) caused by (PCV-2) includes the subclinical infection (PCV-2-SI), systemic (PCV-2-SD) and reproductive (PCV-2-RD) diseases, and porcine dermatitis and nephropathy syndrome (PDNS). Criteria to establish the diagnosis of these conditions have not changed over the years; thus, the triad composed by clinical signs, lesions and viral detection in lesions are still the hallmark for PCV-2-SD and PCV-2-RD. In contrast, PCV-2-SI diagnosis is not usually performed since this condition is perceived to be controlled by default through vaccination. PDNS is diagnosed by gross and histopathological findings, and PCV-2 detection is not recognized as a diagnostic criterion. Molecular biology methods as a proxy for PCVD diagnoses have been extensively used in the last decade, although these techniques should be mainly considered as monitoring tools rather than diagnostic ones. What has changed over the years is the epidemiological picture of PCV-2 through the massive use of vaccination, which allowed the decrease in infectious pressure paralleled with a decrease in overall herd immunity. Consequently, the need for establishing the diagnosis of PCVD has increased lately, especially in cases with a PCV-2-SD-like condition despite vaccination. Therefore, the objective of the present review is to update the current knowledge on diagnostic criteria for PCVDs and to contextualize the interest of using molecular biology methods in the overall picture of these diseases within variable epidemiological scenarios of PCV-2 infection.
目前关于由猪圆环病毒2型(PCV - 2)引起的猪圆环病毒病(PCVD)的知识包括亚临床感染(PCV - 2 - SI)、全身性疾病(PCV - 2 - SD)、繁殖障碍性疾病(PCV - 2 - RD)以及猪皮炎肾病综合征(PDNS)。多年来,确立这些病症诊断的标准并未改变;因此,由临床症状、病变以及病变部位的病毒检测组成的三联征仍是PCV - 2 - SD和PCV - 2 - RD的诊断标志。相比之下,通常不进行PCV - 2 - SI的诊断,因为人们认为这种情况通过疫苗接种默认得到控制。PDNS通过大体和组织病理学检查结果进行诊断,PCV - 2检测不被视为诊断标准。在过去十年中,分子生物学方法作为PCVD诊断的替代方法被广泛使用,尽管这些技术应主要被视为监测工具而非诊断工具。多年来发生变化的是通过大规模疫苗接种呈现出的PCV - 2流行病学情况,这使得感染压力降低,同时整体猪群免疫力也下降。因此,近来确立PCVD诊断的需求有所增加,尤其是在尽管接种了疫苗但出现类似PCV - 2 - SD病症的情况下。因此,本综述的目的是更新关于PCVD诊断标准的现有知识,并在PCV - 2感染的不同流行病学场景中,将使用分子生物学方法的意义置于这些疾病的整体情况中进行考量。